KEGG   PATHWAY: dle04934
Entry
dle04934                    Pathway                                
Name
Cushing syndrome - Delphinapterus leucas (beluga whale)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
dle04934  Cushing syndrome
dle04934

Disease
H01431  Cushing syndrome
Organism
Delphinapterus leucas (beluga whale) [GN:dle]
Gene
111163022  MAPK1; mitogen-activated protein kinase 1 isoform X1 [KO:K04371] [EC:2.7.11.24]
111163031  MC2R; adrenocorticotropic hormone receptor [KO:K04200]
111163122  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
111163175  [KO:K06621]
111163319  WNT4; protein Wnt-4 isoform X1 [KO:K00408]
111163373  E2F2; transcription factor E2F2 isoform X1 [KO:K09389]
111163867  MRAP; LOW QUALITY PROTEIN: melanocortin-2 receptor accessory protein [KO:K22398]
111163985  AGT; angiotensinogen [KO:K09821]
111164225  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
111164400  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
111164599  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
111164765  PDE8A; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A isoform X2 [KO:K18437] [EC:3.1.4.53]
111164991  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
111165107  [KO:K00497] [EC:1.14.15.4]
111165393  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
111165617  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
111165653  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
111165994  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
111165995  LDLR; low-density lipoprotein receptor [KO:K12473]
111166066  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
111166195  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 [KO:K09048]
111166302  CACNA1G; voltage-dependent T-type calcium channel subunit alpha-1G isoform X1 [KO:K04854]
111166674  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
111166868  KMT2A; histone-lysine N-methyltransferase 2A isoform X1 [KO:K09186] [EC:2.1.1.354]
111167181  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
111168040  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
111168340  CACNA1S; voltage-dependent L-type calcium channel subunit alpha-1S [KO:K04857]
111168811  WNT7A; protein Wnt-7a [KO:K00572]
111169236  PBX1; pre-B-cell leukemia transcription factor 1 isoform X1 [KO:K09355]
111169279  WNT9A; protein Wnt-9a [KO:K01064]
111169289  WNT3A; protein Wnt-3a [KO:K00312]
111169438  CTNNB1; catenin beta-1 [KO:K02105]
111169490  CACNA1F; voltage-dependent L-type calcium channel subunit alpha-1F isoform X1 [KO:K04853]
111169763  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
111170218  FZD2; frizzled-2 [KO:K02235]
111170519  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
111170705  [KO:K00513] [EC:1.14.14.16]
111170946  ATF6B; LOW QUALITY PROTEIN: cyclic AMP-dependent transcription factor ATF-6 beta [KO:K09049]
111171472  WDR5B; WD repeat-containing protein 5B [KO:K14963]
111171490  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
111171650  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
111171737  FZD7; frizzled-7 [KO:K02432]
111171769  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
111171775  FZD5; frizzled-5 [KO:K02375]
111172090  WNT6; protein Wnt-6 [KO:K00445]
111172091  WNT10A; protein Wnt-10a [KO:K01357]
111172300  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
111172355  [KO:K00512] [EC:1.14.14.19 1.14.14.32]
111172662  WNT8B; protein Wnt-8b [KO:K00714]
111172890  ATF2; cyclic AMP-dependent transcription factor ATF-2 isoform X1 [KO:K04450]
111172908  PDE11A; dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A isoform X1 [KO:K13298] [EC:3.1.4.17 3.1.4.35]
111173388  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
111173511  ASH2L; set1/Ash2 histone methyltransferase complex subunit ASH2 isoform X1 [KO:K14964]
111173513  STAR; steroidogenic acute regulatory protein, mitochondrial [KO:K16931]
111173766  RAP1B; ras-related protein Rap-1b [KO:K07836]
111173824  CDK4; cyclin-dependent kinase 4 isoform X1 [KO:K02089] [EC:2.7.11.22]
111173897  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
111173942  SP1; transcription factor Sp1 [KO:K04684]
111173945  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
111173979  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
111174034  KMT2D; histone-lysine N-methyltransferase 2D isoform X1 [KO:K09187] [EC:2.1.1.354]
111174035  ADCY6; adenylate cyclase type 6 isoform X1 [KO:K08046] [EC:4.6.1.1]
111174054  WNT10B; protein Wnt-10b [KO:K01357]
111174055  WNT1; proto-oncogene Wnt-1 [KO:K03209]
111174169  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
111174269  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
111174277  CACNA1D; voltage-dependent L-type calcium channel subunit alpha-1D isoform X1 [KO:K04851]
111174368  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
111174571  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
111174766  POMC; pro-opiomelanocortin [KO:K05228]
111174980  KCNK3; potassium channel subfamily K member 3 [KO:K04914]
111175000  ADCY3; adenylate cyclase type 3 isoform X1 [KO:K08043] [EC:4.6.1.1]
111175081  RB1; retinoblastoma-associated protein [KO:K06618]
111175798  CDKN2C; cyclin-dependent kinase 4 inhibitor C [KO:K06622]
111176594  CACNA1C; voltage-dependent L-type calcium channel subunit alpha-1C [KO:K04850]
111176602  WNT5B; protein Wnt-5b [KO:K00444]
111176781  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
111176861  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 isoform X1 [KO:K04959]
111176917  NR5A1; steroidogenic factor 1 isoform X1 [KO:K08560]
111177067  WDR5; WD repeat-containing protein 5 [KO:K14963]
111177564  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
111177653  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
111177745  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
111177811  [KO:K00498] [EC:1.14.15.6]
111177938  FZD8; frizzled-8 [KO:K02375]
111177962  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
111178380  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
111178556  ADCY2; adenylate cyclase type 2 isoform X1 [KO:K08042] [EC:4.6.1.1]
111178692  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 isoform X1 [KO:K04960]
111178743  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
111179093  WNT16; protein Wnt-16 [KO:K01558]
111179238  WNT2; protein Wnt-2 [KO:K00182]
111179290  AGTR1; type-1 angiotensin II receptor [KO:K04166]
111179814  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
111179902  [KO:K00070] [EC:1.1.1.145 5.3.3.1]
111180010  CRHR2; corticotropin-releasing factor receptor 2 isoform X1 [KO:K04579]
111180026  WNT2B; protein Wnt-2b isoform X1 [KO:K00182]
111180034  RAP1A; ras-related protein Rap-1A [KO:K04353]
111180070  GNAI3; guanine nucleotide-binding protein G(i) subunit alpha [KO:K04630]
111180225  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
111180361  FZD6; frizzled-6 [KO:K02376]
111180416  CCNE2; G1/S-specific cyclin-E2 isoform X1 [KO:K06626]
111180740  FZD1; frizzled-1 [KO:K02432]
111180943  CDK6; cyclin-dependent kinase 6 isoform X1 [KO:K02091] [EC:2.7.11.22]
111180958  CCNE1; G1/S-specific cyclin-E1 isoform X1 [KO:K06626]
111181407  E2F3; transcription factor E2F3 isoform X2 [KO:K06620]
111181599  USP8; ubiquitin carboxyl-terminal hydrolase 8 isoform X1 [KO:K11839] [EC:3.4.19.12]
111181753  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
111181799  AHR; aryl hydrocarbon receptor [KO:K09093]
111182103  ARMC5; armadillo repeat-containing protein 5 [KO:K22499]
111182181  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
111182319  FZD9; frizzled-9 [KO:K02842]
111182442  TCF7; transcription factor 7 isoform X1 [KO:K02620]
111182565  WNT8A; protein Wnt-8a [KO:K00714]
111182576  WNT3; proto-oncogene Wnt-3 [KO:K00312]
111182580  CRHR1; corticotropin-releasing factor receptor 1 isoform X1 [KO:K04578]
111182912  AXIN2; axin-2 isoform X1 [KO:K04385]
111182925  WNT9B; protein Wnt-9b [KO:K01064]
111183091  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1 [KO:K04515] [EC:2.7.11.17]
111183530  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1 [KO:K04515] [EC:2.7.11.17]
111183632  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
111183639  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
111183666  AIP; AH receptor-interacting protein isoform X1 [KO:K17767]
111183792  MEN1; menin isoform X1 [KO:K14970]
111183812  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
111183987  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
111184273  E2F1; transcription factor E2F1 isoform X1 [KO:K17454]
111184516  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
111184534  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
111184548  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
111184609  KCNK2; potassium channel subfamily K member 2 [KO:K04913]
111184778  RBBP5; retinoblastoma-binding protein 5 isoform X1 [KO:K14961]
111184814  WNT11; protein Wnt-11 [KO:K01384]
111184951  FZD4; frizzled-4 [KO:K02354]
111185093  AXIN1; axin-1 isoform X1 [KO:K02157]
111185133  CACNA1H; voltage-dependent T-type calcium channel subunit alpha-1H isoform X1 [KO:K04855]
111185142  PDE8B; high affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B isoform X1 [KO:K18437] [EC:3.1.4.53]
111185250  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
111185390  FZD3; frizzled-3 [KO:K02329]
111185582  CRH; corticoliberin [KO:K05256]
111185664  DVL2; segment polarity protein dishevelled homolog DVL-2 isoform X4 [KO:K02353]
111185842  AIPL1; aryl-hydrocarbon-interacting protein-like 1 [KO:K17767]
111186068  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
111186212  ATF4; cyclic AMP-dependent transcription factor ATF-4 isoform X1 [KO:K04374]
111186225  CACNA1I; voltage-dependent T-type calcium channel subunit alpha-1I isoform X1 [KO:K04856]
111186418  WNT7B; protein Wnt-7b isoform X1 [KO:K00572]
111186741  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
111186746  [KO:K04632]
111186877  ORAI1; calcium release-activated calcium channel protein 1 [KO:K16056]
111186950  FZD10; frizzled-10 [KO:K02842]
111187005  SCARB1; scavenger receptor class B member 1 isoform X1 [KO:K13885]
111187117  DVL1; segment polarity protein dishevelled homolog DVL-1 isoform X1 [KO:K02353]
111188007  CREB3; cyclic AMP-responsive element-binding protein 3 [KO:K09048]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
dle00020  Citrate cycle (TCA cycle)
dle00140  Steroid hormone biosynthesis
dle04020  Calcium signaling pathway
dle04024  cAMP signaling pathway
dle04110  Cell cycle
dle04310  Wnt signaling pathway
dle04927  Cortisol synthesis and secretion
dle04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   

DBGET integrated database retrieval system